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Abstract
Head and neck irradiation is the standard treatment of advanced oral/oropharyngeal can-
cer. The treatment has severe side effects such as mucositis, xerostomia, irradiation caries, 
trismus, and osteoradionecrosis. Side effects can lead to treatment discontinuation, infec-
tion, increased drug consumption, and increased duration of hospital admission and can 
have negative impact on the quality of life and overall survival. Furthermore, some of them 
(mucositis and xerostomia) affect almost every (>90%) patient. Since nearly two‐thirds of 
oral/oropharyngeal cancers are diagnosed in advanced stage, one might conclude that the 
great majority of patients will be affected. However, these side effects can be prevented 
or at least reduced by proper oral/dental care. Therefore, every patient planned for head 
and neck irradiation should undergo dental evaluation before beginning of the treatment.
Keywords: oral cancer, radiotherapy, mucositis, xerostomia, osteoradionecrosis, 
radiation caries
1. Introduction
Head and neck irradiation is the standard treatment of advanced oral/oropharyngeal cancer. 
Most often, radiotherapy (RT) is delivered after surgery, alone or in combination with chemo-
therapy to assure better locoregional control. Indication for postoperative radio‐/chemoradio-
therapy includes: T3 or T4 tumor, close (<5 mm) or positive surgical margin, positive cervical 
lymph nodes with or without extracapsular spread, lymphovascular and/or perineural inva-
sion. RT can be delivered as a primary treatment in cases of unresectable disease, compro-
mised patient's health, unfavorable cosmetic, or functional outcome of anticipated surgery 
and recurrent disease with multiple previous surgeries [1].
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
Attribution L cense (http://creativecommons. /licenses/by/3.0), which permits unrestricted use,
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Head and neck cancer patients usually receive the total dose of 60–70 Gy divided into 2 Gy 
daily fractions (5 days a week) over 6–7 weeks. Along with therapeutic action on tumor cells, 
ionizing radiation causes damage to surrounding healthy tissues located in the radiation 
field. Radiation induced damage to surrounding healthy tissues is responsible for complica-
tions that arise during and after radiotherapy. There are several reasons why these complica-
tions are very frequent in the oral cavity:
• fast turnover rate of oral mucosal cells
• rich and complex oral microflora
• mucosal microtrauma during mastication [2]
Most orofacial complications are dose‐dependent and side effects occur when doses greater 
than 45 Gy are delivered. Apart from the total dose, intensity of oral side effects depends 
on the fraction size and scheduling, field size/affected tissue volume, and concomitant use 
of chemotherapy. In order to minimize the irradiation damage to surrounding tissue, novel 
techniques such as 3D (three‐dimensional) conformal radiotherapy and intensity‐modulated 
radiotherapy (IMRT) are introduced. These techniques allow more precise design of radiation 
field enabling delivery of high doses to the target tissue while reducing doses to surrounding 
structures [3].
Radiation‐related oral side effects can be acute or chronic. Acute side effects begin during the 
RT and last several weeks after the therapy cessation. Acute side effects include
• oral mucositis
• taste disorder
• xerostomia
Chronic oral side effects begin several weeks, months, or even years after the RT. Chronic side 
effects are as follows:
• trismus
• radiation‐induced dental caries
• osteoradionecrosis [4]
Patients undergoing RT demand a multidisciplinary approach in order to reduce the intensity 
of radiation‐induced oral side effects and understand the role of dentist and themselves in 
their prevention and therapy.
2. Acute side effects of head and neck irradiation
2.1. Oral mucositis
Oral mucositis (OM) is the most common complication of head and neck irradiation affecting 
80–90% of the patients. Oral mucositis is defined as reactive inflammation of oral mucosa due 
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to radiation‐induced damage of cellular DNA and subsequent cellular death of basal kerati-
nocytes. Mucositis manifests as ulcerative inflammation of the oral mucosa (Figure 1) which 
can cause severe pain, deteriorated oral function, increased drug consumption, and can lead 
to temporary treatment interruption with consequent reduction in therapeutic effect [4].
Pathogenesis of oral mucositis can be divided into five stages: initiation, upregulation/activa-
tion, signal amplification, ulceration, and healing. First step, initiation is characterized by 
radiation‐induced DNA damage and generation of reactive oxygen species (ROS). In the next 
step, ROS activate nuclear factor‐κB (NF‐κB) transcription factor, which further upregulates 
genes responsible for the synthesis of pro‐inflammatory cytokines like interleukin 6 (IL‐6) 
and tumor necrosis factor alpha (TNF‐α). As the RT continues, generated pro‐inflammatory 
cytokines further amplify inflammatory mucosal damage by providing positive feedback on 
NF‐κB activation. In the next stage, patients develop ulcerations which are colonized by oral 
microorganisms that further promote epithelial damage. Last stage characterized by healing 
of the ulcers occurs when radiation‐induced DNA damage stops [5].
First clinical sign of oral mucositis is whitish appearance of oral mucosa which begins at the 
end of the first week of irradiation. In the third week, patients usually develop ulcerations 
covered with fibrinous pseudomembranes that are prone to secondary infection. Mucositis 
persists throughout the radiotherapy with a peak at the end of irradiation and lasts for 2–4 
weeks after treatment cessation. Intensity of mucositis is strongly dependent on the total dose, 
fraction size, field size, number and frequency of fraction delivery, and type of ionizing irra-
diation [4, 5].
Even though there are numerous scales for the assessment/classification of mucositis available, 
most commonly used scoring system is the one established by the World Health Organization 
[6–9]. The scoring system is very simple to apply and based on patient's ability to eat solid 
food. According to WHO, oral mucositis can be divided into four stages as follows [9]:
Figure 1. Oral mucositis.
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• stage 0 = no pain
• stage 1 = erythema and mild edema
• stage 2 = erythema and ulcers, patient is able to eat solid food
• stage 3 = erythema and ulcers, patient is unable to eat solid food
• stage 4 = peroral alimentation is not possible
There is still no effective agent that could prevent the development of oral mucositis in patients 
undergoing head and neck irradiation [10]. The treatment of oral mucositis therefore remains 
symptomatic, aimed at relieving pain, preventing infection of oral lesions, and maintaining 
normal functioning of oral cavity.
2.2. Xerostomia
Xerostomia is one of the most frequent and debilitating side effects of head and neck RT. It 
develops acutely (early in the course of irradiation), but frequently remains chronic (perma-
nent) complication (Figure 2). Lack of saliva affects the health of the entire oral cavity and 
favors the occurrence of other oral complications, which impair patient's quality of life, such 
as development of dental caries, oral infections, dysgeusia, dysphagia, oral discomfort, and 
pain [11]. Major salivary glands produce 70–80% of the total salivary flow. Parotid gland pre-
dominantly produces stimulated, watery saliva, and its serous acinar cells are more radiosen-
sitive than mucous cells of submandibular and sublingual glands [12]. It seems that the extent 
of parotid irradiation is a major contributing factor for the development of xerostomia, as well 
as a total dose of received irradiation [3]. Xerostomia often remains permanent if radiation 
dose is greater than 40 Gy. Head and neck tumors are usually treated with a total dose greater 
than 60 Gy, during 6 weeks, which can lead to decrease in salivary production by 80% [2]. 
Figure 2. Xerostomia.
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Together with quantitative effect on salivary flow, RT also changes the composition of saliva. 
Concentration of different ions and proteins in saliva rises, while the bicarbonate concentra-
tion decreases, causing a low salivary pH and a low buffering capacity [13, 14]. Quantitative 
and qualitative changes in saliva seriously impair patient's quality of life. Sparing salivary 
glands during irradiation, if possible, can reduce the long‐term reduction in salivary flow [11].
2.3. Taste disorder
During the RT, majority of patients experience complete or partial taste loss. According to a 
recent literature review, taste disorder affects 66.5% of patients undergoing RT alone and 76% 
of patients undergoing combined chemoradiotherapy [15].
Taste disorder is a result of two factors: (i) a direct radiation effect on the taste buds and (ii) 
changes in salivary flow and composition. Taste buds are very sensitive to irradiation and 
demonstrate signs of degeneration and atrophy at doses of 10 Gy [4]. Decreased salivary flow 
disrupts transport of flavor molecules to taste buds while changed ionic composition of saliva 
further impairs taste perception. Most patients report their taste disorder as mild. Impact of 
taste disorder on the quality of life is difficult to assess because patients often report taste dis-
order along with other, more severe side effects of head and neck irradiation like xerostomia, 
sticky saliva, and difficulty swallowing [15].
In majority of cases, taste gradually returns to normal or near‐normal levels within 1 year 
after RT. Because of this transitory aspect, there is usually no need for treatment. However, 
in around 15% of patients, taste disorder can last longer. There have been cases of patients 
whose taste disorder lasted 5–7 years after RT. To date, no universally recommended preven-
tive or management strategies are available [15].
3. Chronic side effects of head and neck irradiation
3.1. Radiation‐induced dental caries
The primary cause of radiation‐induced dental caries is change in quality and quantity of saliva, 
due to radiation‐induced salivary gland damage. After RT, salivary viscosity is increased and 
its buffering capacity and pH are reduced. Salivary pH becomes cariogenic, decreasing from 
7.0 to 5.0 and making minerals of enamel and dentin dissolve easily [16]. A defensive role of 
saliva is impaired, which leads to changes in oral flora of these patients. Within 3 months of 
completing RT, oral flora becomes more acidogenic and cariogenic because of increased con-
centration of Streptococcus mutans, Lactobacillus, and Candida species [17, 18]. If the teeth are 
located in the irradiation field, irradiation also has a direct destructive effect on dental hard 
tissue, causing decreased circulation through pulp, secondary fibrosis, and degeneration of 
the odontoblast processes. As shown from the literature, the effect of irradiation on tooth 
structure is dose‐dependent. Doses lower than 30 Gy cause minimal tooth damage, doses 
30–60 Gy increase risk of tooth breakdown two to three times while doses greater than 60 Gy 
increase risk of tooth damage 10 times [19]. Radiation‐induced caries characteristically has a 
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quick progress and affects smooth tooth surfaces where caries in nonradiated patients seldom 
occurs. The affected teeth become discolored and demineralized, with erosions in the cervical 
region, which makes them fracture easily (Figure 3). Despite advanced clinical presentation, 
the lesions are painless [16]. The risk of occurrence of radiation caries is lifelong so patients 
should be instructed to maintain adequate oral hygiene and to come to regular dental check-
ups every 1–3 months.
3.2. Osteoradionecrosis
Osteoradionecrosis (ORN) is the most serious complication of head and neck RT, which affects the 
bone in irradiated area. RT alters collagen synthesis and induces inflammation and obliteration 
of the blood vessels that provide blood supply to the bone. Irradiated bone becomes hypovas-
cularized and hypoxic, with impaired healing capacity [20]. The process is irreversible and 
progressive, and the risk of osteonecrosis is lifelong. The most commonly used definition of 
ORN implies exposed bone without healing for 3 months, without recurrence of the tumor 
[2], although there is no universally accepted definition in the literature. Due to the disagree-
ment about the definition, there are no accurate data about the prevalence and incidence of 
ORN in the jaws. The reported relative frequency of ORN is between 0 and 7.1%, but patients 
with tumors localized in the oral cavity have higher relative frequency of ORN, up to 13.6% 
[21]. Results from one literature review report a weighed ORN prevalence of 7.4% for conven-
tional radiotherapy, 5.1% for IMRT, 6.8% for chemoradiotherapy, and 5.3% for brachytherapy 
[22]. The literature shows that two‐thirds of ORN in the orofacial region appear after a trau-
matic event, such as tooth extractions, ill‐fitting dentures, biopsies, or periodontal dental pro-
cedures, while one‐third can appear spontaneously. The most frequently affected bone in the 
head and neck region is the mandible [21, 22].
Figure 3. Radiation caries.
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Risk factors for the development of ORN include therapeutic dose and mode of irradiation 
or combined chemotherapy and radiotherapy. Doses greater than 60 Gy, use of brachyther-
apy, or combined chemo‐ and radiotherapy increases the risk of development of ORN, while 
hyperfractioned RT or moderately accelerated fractioned RT, even in greater doses, decrease 
the risk of its occurrence [23]. Other risk factors include poor oral hygiene, malnutrition, 
chronic trauma from ill‐fitting dentures, or acute trauma from surgical procedures in the jaw, 
especially in posterior mandible [24].
ORN manifests as an area of exposed bone in the oral cavity (Figure 4). Symptoms of ORN 
include pain, dysgeusia, dysesthesia, halitosis, or food impaction in the area of exposed bone, 
although in early stages it can be asymptomatic. Untreated, it can lead to fistulas and patho-
logical fractures of the bone (Figure 5) [20–24]. Still, there is no universally accepted classifica-
tion system for ORN, which makes comparison of different studies difficult [25].
3.3. Trismus
Trismus can occur if temporomandibular joint and masticatory muscles are located in irradi-
ated area during head and neck cancer therapy. Irradiation causes spasm and fibrosis of mas-
ticatory muscles, which limits mouth opening [26, 27]. Trismus is often defined as reduced 
mouth opening with interincisal space less than 35 mm, but there is no universally accepted 
definition in the literature which is the reason for a wide range of reported prevalence of 
trismus after head and neck RT, ranging from 5 to 38% of patients [28, 29]. Trismus is often 
underreported as RT side effect, although it seriously impairs quality of life, resulting with 
difficulties in patient's social life, affecting speech, food intake, and oral hygiene maintaining 
and even leading to depression [30]. Risk factors for the occurrence of the trismus are similar 
as for other late oral side effects of RT and include the total dose of radiation, fractionation 
Figure 4. Osteoradionecrosis.
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regimen (mode of irradiation), treatment modality (conventional RT vs. intensity‐modulated 
radiotherapy (IMRT)), overall duration of RT, tumor location, and poor physical condition 
[26, 27, 31, 32]. Some results show that a total dose of RT greater than 55 Gy increases the 
incidence of trismus up to 47%, while treatment modality as conventional RT compared to 
IMRT decreases the mean incidence of trismus from 25.4 to 5% [27, 33]. Patients receiving RT 
to head and neck area should be instructed in rehabilitative exercises during and after RT to 
prevent the trismus development.
4. Dentist's role in head and neck cancer team
As early as 1995, experts of the health system of the United Kingdom concluded that health 
policy in addition to acting on the length of survival of patients with head and neck tumors 
(PwHNTs) must take all measures to increase their quality of life [34].
Over decades, modern treatment modalities have increased the survival rate of these patients, 
owing to the great efforts invested. However, it is obvious that the quality of life to which 
PwHNTs are destined is far below the level of being comfortable and functional [35]. The 
function of the upper aerodigestive tract is impaired following the treatment in PwHNT, espe-
cially of structures related to the oral tissues. The function of the mouth is a very important 
aspect of the quality of life of cancer patients in general [36]. While significant developments 
occur in the field of treatment, especially in terms of procurement of modern equipment for 
RT, as well as in education of radiation oncologists and medical physicists, which improves 
the survival rate of patients, we have to ask ourselves: what about the quality of life of our 
PwHNT following RT?
Oral toxicities related to RT are discussed in detail elsewhere in the text. Although oral muco-
sitis does not last longer than a few weeks after completion of RT, its most serious consequence 
is interruption of RT [37]. The practice in which oncologists would temporarily interrupt radi-
ation in case of severe form of mucositis “until the PwHNT gets his oral  situation improved” 
Figure 5. Osteoradionecrosis progressing to pathological fracture of the mandible (Courtesy of Prof. Alajbeg).
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might still exist. This practice reduces the cure rate by 1–2% per each day of interruption [38]. 
Therefore, the dentists must take all measures to help PwHNT withstand the uninterrupted 
treatment, no matter how uncomfortable it gets.
Although it might require a lot of effort in continuous communication with oncology sur-
geons and oncologists, our profession must strive to provide arguments against interruption 
of radiation. Dentists need to convince oncologists that good preparation of PwHNT and 
close monitoring during RT at 2‐week intervals can effectively prevent the need for interrup-
tion of RT, and this practice should be ever so rarer. Centers that include collaborative dentist 
would not normally interrupt radiation in cases of severe mucositis.
As discussed elsewhere in the chapter, there are also lifelong complications of head and neck 
RT, which ultimately can cause pathological fractures of the jaw and, indirectly, death. It is 
a cascade process with connected temporal occurrences. Briefly described, it begins with the 
destruction of acini of the salivary glands by radiation. The teeth, as there is no saliva, cannot 
defend demineralization, which leads to the inevitable radiation caries. The destruction of 
tooth leads toward the need for extraction, which is a high‐risk procedure in the irradiated 
bone, because of RT‐induced hypovascularity, ultimately leading toward ORN [39]. ORN 
can be so extensive that it may cause pathological fracture of the mandible (Figure 5). This 
“domino effect” could be prevented if dental profession is included into multidisciplinary 
approach.
Good protocols for an interdisciplinary approach to PwHNT clearly emphasize that the den-
tist is a part of the oncology team [40]. Unfortunately, is not usually so. There are exceptions in 
most developed countries, but it really is not a part of standard of care, especially in develop-
ing countries such as Croatia. The causes of such inappropriate practices lay on both sides of 
the bridge: medical doctor (head and neck surgeon) generally is not aware of the true signifi-
cance and is not easily bothered to spend his limited energy on oral complications. A dentist, 
on the other hand, often has “better things to do” than to deal with a handful of neglected 
people of low socioeconomic status, who seem hopelessly ill. It could be due to personal 
ignorance on the subject, and due to a fear to treat PwHNT. And so, our task is twofold: as 
representatives of the profession called “oral medicine” to build a bridge between our fellow 
dentists and fellow medical doctors, and to strive to persuade them how important it is to 
cooperate. In addition, we have to introduce an educational intervention among fellow den-
tists to foster their engagement in this important activity. What we still do not know is how 
to motivate fellow dentists to enthusiastically participate in the care of PwHNT. Until then, 
only few institutions in Croatia, such as ours, will remain one of the few places that provide 
this type of care.
Dentists’ activities are directed to adherence to guidelines for oral care, which improve the 
quality of life in PwHNT, especially those who are treated with RT. Those include the reduc-
tion of the inevitable side effects of treatment, as well as the prevention of long‐term compli-
cations of treatment.
Oral care needs to be based on the good practices from developed countries. The US National 
Comprehensive Cancer Network (“National Comprehensive Cancer Network,” NCCN) brings 
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together 26 of the top cancer centers in the United States and publishes guidelines for good 
clinical practice of treating head and neck tumors [41]. According to their guidelines, it is clearly 
stated that patients should be referred to dental evaluation before the treatment of any head 
and neck cancer site: lip cancer, oral cavity, oropharynx, hypopharynx, nasopharynx, glottic, 
and supraglottic larynx, paranasal sinuses (pp. 11–59). With the obligatory oral and dental 
evaluation and treatment before cancer treatment, NCCN guidelines emphasize the necessary 
oral evaluation and care during and after radiotherapy, stating that dental evaluation is rec-
ommended for oral cavity and all sites exposed to significant radiotherapy (p. 83) [41]. As a 
mandatory postulate, the NCCN approach describes the integration of treatment, stating that 
it is critically important that a multidisciplinary evaluation and treatment are prospectively 
coordinated and integrated by all disciplines involved in the care before starting any treatment 
(p. 84) [41].
Timing of RT as the part of multimodal treatment is important. It is well established that time 
elapsed between surgery and RT inversely affects the prognosis [42]. There are, however, 
papers questioning this concept, but today it is considered the best to start RT 6 weeks fol-
lowing the surgery [43]. This leaves enough time for dental treatment to be completed before 
the RT.
However, it is not unusual that dentists sees PwHNT scheduled for RT, who comes at their 
first dental appointment only several days before the actual start of RT. If a dentist extracts 
their teeth, he would be causing further postponing of RT, which may be disastrous for the 
patient. Today, thanks to better planning in health care, waiting for RT is not so long anymore 
(at least in the institutions we work with), but the PwHNTs also come to point of oral care 
soon after discharge after surgery, which is early enough so that all dental procedures can be 
performed at a normal pace prior to the RT. This minimizes the risk of toxicities, eliminating 
the need for extractions after radiation. During and after RT, specific procedures are followed, 
as discussed elsewhere in the chapter.
Guidelines of the British Society for Disability and Oral Health, by Kumar et al., offer an 
elaborate approach to pathways of oral care in PwHNT [44]. Their basic postulate, without 
which we will certainly fail, is that clear pathway of care is necessary if we want to prevent 
or minimize oral complications. Regardless of how simple this may look, the lack of “clear 
pathway of care” was what caused the previous absence of this specific care. It requires strong 
dedication, exceptional effort, time, and preparedness for countless disappointments along 
the journey our profession takes in order to foster this type of oral care.
One should be aware that most of PwHNTs are not easy to motivate for compliance to oral 
care. It is very difficult to explain PwHNT how important the preventative effect of fluorida-
tion is, when combined with good oral hygiene. A typical PwHNT has a history of consum-
ing large amounts of alcohol and tobacco products, and is not easily motivated to suddenly 
start adhering to very strict oral hygiene measures. However, the efforts lead to success in a 
considerable number of patients.
Dentists should be aware of obstacles inherent in most health systems. One of them is was 
that primary care dentists usually are unprepared and uninterested to participate in oral care. 
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The probable reason is the lack of specific knowledge and skills. These patients should be 
continuously motivated, closely followed up, and helped to obtain good adherence to our 
recommendations. If their primary care dentist is not collaborating with specialists, PwHNT 
most certainly will not comply.
Specialists should write very extensive medical histories, explaining the primary care 
dentist what and why certain dental procedures must be done in their offices and the 
therapeutic rationale behind these procedures. These are written dental recommendations 
with an educational component. Secondary and tertiary care professionals who coordinate 
oral care should always clearly emphasize that they would be available for telephone or 
other types of consultation. Furthermore, it has been noted that the advice on oral and 
dental complications of head and neck RT treatment communicated by head and neck 
surgeon had much more impact on patients than if that same advice was communicated 
by the responsible dentist. It is therefore of utmost importance that head and neck surgeon 
possesses basic knowledge of the subject matter and that is willing to firmly insist that 
PwHNT complies with oral health measures. Regardless of how disappointing this might 
be for oral care professionals, this discovery is very important and should help guiding 
efforts to change oral behavior in our PwHNT. Head and neck surgeons who assume a role 
of “oral health advocates” can help dentists to significantly increase patients’ compliance. 
We have observed that if surgeons also motivate patients for good oral care, a significant 
increase in compliance with the recommendations will be achieved [45]. The ideal would 
be that the oral assessment is introduced as a legal requirement before the radiation of the 
head and neck. Listed experiences should be of practical help to readers who plan to start 
this service [46].
5. Dental management prior radiation therapy for head and neck cancers
Prior to the head and neck RT, all patients without exception should be referred for oral/dental 
care. There are no generally accepted evidence‐based clinical guidelines for dentists how to 
prepare patients for RT; however, it is rational to follow effective strategies from the relevant 
literature [47].
The main purposes of pretreatment dental evaluation are as follows:
• to prevent or minimize acute and chronic oral side effects associated with RT
• to facilitate submission of RT and radiation‐induced sequelae
(1) The task of the dentist, as a member of the oncology team preparing the patients for head 
and neck RT, is to perform the following procedures:
(a) treatment of oral and dental diseases
(b) implementation of preventive procedures
(c) education of the patients
Oral Side Effects of Head and Neck Irradiation
http://dx.doi.org/10.5772/intechopen.68961
121
5.1. Treatment of oral and dental diseases
Since treating diseased oral tissues prior to RT prevents or minimizes the development of 
many radiation‐induced complications, a thorough oral examination before RT is essential. 
The fact that some patients are edentulous does not mean that for them dental management 
before, during, and after radiotherapy is not or is less important.
In order to reveal the presence of periapical lesions, impacted teeth, general bone conditions, 
and tumor rarefications, a panoramic radiograph is performed [48]. Dental caries with or 
without root canal infection, necrotic pulps, periodontitis, periodontal abscesses, diseases of 
oral mucosa are additionally assessed trough clinical dental evaluation. Oral status is eval-
uated and recorded: present teeth, clinical and radiographic findings (carious lesions, oral 
mucosa status, periodontal status, salivary gland functional assessment, interincisal opening), 
presence of orthodontic devices, and denture use.
Prophylactic dental clearance includes restorative treatments, periodontal scaling, fluoride 
therapy, and dental extractions. The following teeth need to be extracted [49]:
• Teeth with advanced caries lesions with questionable pulpal status or pulpal involvement
• Teeth with extensive periapical lesions
• Teeth with signs of severe periodontal disease (advanced bone loss and mobility or furca-
tion involvement)
• Residual root tips not fully covered with bone or showing radiolucency
• Impacted or incompletely erupted teeth, particularly third molars that are not fully cov-
ered by alveolar bone or that are in contact with the oral environment
Three weeks before radiation therapy begins, all dental treatments should be completed. In 
the case there is less than 10 days to the beginning of the RT, teeth extractions are delayed for 
the “window” period after radiation (within 5–6 months after completion of RT) [50].
5.2. Implementation of preventive procedures
The elimination of all potential causes of local trauma is mandatory. It is known that ORN can 
develop also in edentulous patients [45] and therefore the adjustment of ill‐fitting dentures is 
necessary. It is important to remove sharp edges and protruding teeth fillings. Orthodontic 
braces should be removed before the beginning of the RT.
5.3. Education of the patients
Besides teeth preservation and elimination of potential trauma, it is necessary that dentist edu-
cates the patient prior to RT. The dentist should explain the expected and possible RT‐induced 
complications. Patients must be aware that the salivary glands may be affected by irradiation, 
which can result in severe decrease of salivary function [51]. Radiation‐induced xerostomia is 
an important chronic side effect of RT that can lead to many oral diseases and patients should 
be warned on the rapid occurrence of dental caries [52]. Untreated on time, it results in the 
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extraction of teeth and the possible development of ORN. During preirradiation, dental man-
agement dentist should strongly emphasize to the patients that postirradiation caries and fol-
lowing oral diseases are avoidable through the regular and meticulous dental hygiene, daily 
fluoridation, and regular dental checkups.
Regrettably, in addition to poor oral health, before RT in many head and neck squamous cell 
carcinoma patients, even from developed countries and regardless of their dental status, poor 
oral hygiene is common [45]. Patients should therefore receive optimal mouth care before RT 
begins. During the preirradiation treatment, it is important that the dentist provides patients 
with instructions for oral hygiene during and after radiation therapy.
It is useful to provide the patient with the Fact Sheets created by the Oral Care Study Group 
of the Multinational Association of Supportive Care in Cancer (MASCC) and the International 
Society of Oral Oncology (ISOO) [53]. These are available online, multilingual, and written in 
plain language and the notable parts of the Fact Sheets are provided below along with their 
original section numbers.
1.3.1. Oral care advices that dentist should give to the patient before RT include instructions 
about [53]
1.3.1.1. proper toothbrushing: “Use a soft toothbrush. Brush before bed. Gently brush tongue. 
Brush within 30 minutes of eating.”
1.3.1.2. dental floss use: “Floss at least once daily with waxed floss.”
1.3.1.3. rinsing: “Rinse, swish and spit rinse several times after brushing or flossing. Ensure 
medicated rinses are done 20 minutes apart.
HOW TO MAKE YOUR MOUTH RINSE 1. Mix 1 teaspoon of baking soda and 1 teaspoon of 
salt with 4 cups of water. 2. Put the mouthwash in a container with a lid. 3. The mouthwash 
should be kept at room temperature. 4. Discard at the end of each day and make a new batch.
HOW TO USE YOUR MOUTH RINSE Shake well before using. • Rinse and gargle with one 
tablespoon (15 mL) and then spit out. • Repeat 2 or 3 times at each use. • Use mouthwash 
every 2 hours during the day.”
1.3.1.4. oral moisturizing: “Moisturize nasal passages through the night with a steam vapor-
izer in your room. Moisturize with mouth rinse and water based lubricants often. Avoid 
petroleum jelly and glycerin products.”
1.3.1.5. lip care: “Use water‐soluble, wax‐based, or oil‐based lubricants. • Apply after clean-
ing, at bedtime and as needed. Do not apply petroleum Jelly.”
1.3.3.6. fluoridation
“INSTRUCTIONS FOR USE OF FLUORIDE TRAYS 1. Brush and floss before wear-
ing trays. 2. Fill the grooves of the trays 1/3 full with gel. 3. Insert tray and spit out 
any excess gel. 4. Leave the tray in for 5 minutes. • Use at bedtime for longer lasting 
results. • Brush trays and air dry after each use. • Do not use hot water to clean trays 
(hot water will distort the tray). • Do not eat, drink or rinse for 30 minutes after tray 
use.”
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Besides explaining how to perform fluoridation, dentist should emphasize the impor-
tance of fluoridation in preventing post‐radiation dental caries.
1.3.1.7. Denture care instructions
“• Keep your dentures out as much as possible. • Remove dentures, plates and pros-
theses before brushing. • Brush and rinse dentures after meals and before bed. • Soak 
dentures in cleansing solution for at least 8 hours. • If you are on antifungal therapy, 
soak in anti‐fungal solution.” [53]
Edentulous patient should also be instructed to remove dentures during RT. [48]
As a member of oncology team, the dentist should also explain to the patients:
1.3.2. The necessity of avoiding the consumption of cigarettes and alcohol
1.3.3. The necessity of regular dental visits during and after RT.
Dental consultation should always be in order prior to RT. During the first pre irradiation 
dental visit, patient should become aware that the dentist plays very important role in the 
management of head and neck cancer. They should realize that dental treatment before, dur-
ing, and after head and neck RT is mandatory part of the more successful oncological therapy, 
which reduces the morbidity and mortality associated with RT.
6. Oral care during head and neck radiotherapy
Oral care during head and neck RT is directed to the treatment of acute complications—oral 
mucositis, xerostomia and taste alterations.
6.1. Oral mucositis
Most pronounced symptom of oral mucositis is pain associated with dysphagia, odynopha-
gia, and difficulty speaking. Symptoms usually begin in the third week of RT. Sometimes 
pain can be so intense that it can prevent oral food intake resulting in the need for parenteral 
nutrition, and in some cases discontinuation of RT. During this period, regular checkups at 
dental office every 7–10 days are recommended [54]. Up to now, a lot of treatment modalities 
for OM have been tested, but most of them with varying success.
The treatment of OM is symptomatic, and it mainly consists of pain management and infec-
tion control. For the pain management, mouthwash containing topical anesthetic agent such 
as lidocaine is usually prescribed. Tetracaine, amethocaine, dyclonine, and benzocaine are also 
used for pain relief. The use of topical anesthetics allows patients to do regular daily activi-
ties such as eating and tooth brushing. Most of the studies, aimed at pain relief, reported less 
frequent interruption of RT, when topical anesthetic is used [55–57]. Administration of sys-
temic analgesics, including opioids, is used in most patients with moderate or severe OM [58]. 
Except topical anesthetic, mouthwash can contain ant‐inflammatory and antimicrobial agents. 
A nonsteroidal anti‐inflammatory drug, benzydamine hydrochloride, is effective in reducing 
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the intensity and duration of mucosal damage [10, 59]. Plaque control and oral hygiene is very 
important in controlling OM. Even though chlorhexidine (CHX) is not recommended in the 
prevention or management of oral mucositis, its administration may provide indirect benefits 
like plaque control and gingivitis prevention, as well as oral candidosis prevention [10]. In 
the case of oral candidosis, local antifungal drugs such as miconazole or nystatin are pre-
scribed [54]. Cytoprotective drug amifostine and biological response  modifiers (interleukin 1, 
interleukin 11, and transforming growth factor β) have also been introduced for management 
of OM, but with varying success and are not recommended [10]. From all of the above men-
tioned, it can be concluded that there is still no effective therapy for the prevention and treat-
ment of OM. However, it is important to emphasize that dentist can significantly contribute to 
the implementation of RT in its entirety, without interrupting it.
6.2. Taste disorder
The prevalence of taste alterations in patients receiving RT is 66.5%, and approximately 15% 
of them continue to experience this problem after cessation of the treatment [15]. Taste dis-
order has a negative impact on quality of life and may cause malnutrition, weight loss, and 
in severe cases, significant morbidity. However, it is important to note that this problem is 
reversible, and in most of the patients spontaneous return of taste occurs within a year and 
therefore no specific treatment is necessary [15]. Additionally, up to now no efficient agent 
for treating or preventing RT related taste disorder exists [15]. Zinc gluconate, amifostine, 
and dietary counseling have been studied for that purpose. Studies that tested administra-
tion of zinc gluconate reported variable results [60, 61]. Zinc gluconate is therefore not recom-
mended for taste disorder prevention in head and neck cancer patients, even though it was 
found to be beneficial in a noncancer idiopathic dysgeusia [15]. It has been shown that use of 
amifostine only modestly helps in reducing the severity of taste disorder, without affecting 
the incidence [62, 63]. Because of conflicting results of the studies which examined the use of 
amifostine in the prevention and/or management of taste disorder, recommendation is not 
to use it in head and neck cancer patients [15]. Use of dietary and educational counseling 
on the incidence and severity of dysgeusia in cancer patients has shown a minor impact on 
early‐onset taste disorder (30% vs. 40%), but with a greater effect on long‐term taste disorder 
(5% vs. 25%) [64].
6.3. Xerostomia
It is well known that salivary gland hypofunction and xerostomia are significant morbid-
ities during and following head and neck RT, resulting in decrease of salivary flow rates. 
Treatment goals for salivary gland hypofunction are stimulation of residual salivary gland tis-
sue, relief of oral dryness, prevention of tooth demineralization, caries, and oral infection [11]. 
Pilocarpine, cevimeline, bethanechol HCl, and amifostine have been tested for the prevention 
of salivary gland hypofunction in cancer patient undergoing RT. Due to conflicting results 
their use is not recommended [11]. On the other hand, recent systematic review suggested 
that both pilocarpine and cevimeline can reduce xerostomia symptoms and increase salivary 
flow compared to placebo after RT but “some aspects of the relevant effect size, duration of the 
benefit, and clinical meaningfulness remain unclear” [65].
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Intensity‐modulated radiation therapy (IMRT) can reduce the radiation dose to salivary glands, 
thus helping in decrease of salivary gland hypofunction and symptoms of xerostomia [66, 67]. 
Surgical transfer of submandibular gland to the submental space can contribute to preserva-
tion of salivary gland function and reducing xerostomia symptoms. However, this method 
applies only to patients with clinically negative cervical lymph nodes [11]. Despite their short‐
term effect, it has been shown that use of saliva substitutes is more effective in the treatment of 
dry mouth than placebo. The saliva substitutes are mainly based on carboxymethylcellulose, 
hydroxypropylmethylcellulose, hydroxyethylcellulose, and plyglycerylmethacrylate. Some of 
them contain electrolytes and fluoride for preventing teeth demineralization. Artificial saliva 
substitutes come in the form of gel, spray, and solution. Because its lubricating effect lasts 
longer, saliva substitute gel is recommended, especially during the night or other periods of 
severe oral dryness [11].
Points to remember for the oral care during head and neck RT are presented in Table 1 [68–70].
7. Oral care after head and neck radiotherapy
After completion of RT, frequent follow‐up appointments at dental office and good oral 
hygiene are of utmost importance. Initially, follow‐up appointments are carried out once a 
month, and subsequently their dynamics is determined individually. Xerostomia and sali-
vary gland dysfunction as acute complication of RT continues in the posttreatment period, 
thereby becoming chronic, which greatly increases the risk of dental caries and its sequelae. 
Radiation caries is extremely progressive and highly destructive type of caries, which cer-
tainly increases the risk of ORN by increasing risk for tooth extraction. Therefore, every effort 
Oral care during head and neck radiotherapy
• regular checkups every 7–10 days during RT
• for the pain management prescribe topical anesthetics and/or analgesics
• use a soft toothbrush with a fluoride toothpaste for brushing after meals and before bed. Floss at least once a day 
(use xylocaine anesthetic rinse prior to brushing and flossing)
• if brushing is too painful, use a clean moist gauze or foam swab soaked in baking soda mouth rinse
• rinse the mouth with a baking soda and salt solution (mix 1 teaspoon of baking soda and 1 teaspoon of sat with 
four cups of water) several times a day. Avoid salt during mucositis
• management of dry mouth (sip water frequently, use saliva substitutes, use sugar‐free candies, and gums)
• keep dentures out of the mouth as much as possible; soak it in cleansing solution for at least 8 hours
• exercises for the jaw muscles at least three times a day to avoid trismus
• avoid spicy or acidic foods, tobacco, and alcohol
Table 1. Oral care during head and neck radiotherapy (modified from Refs. [68–70]).
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should be focused on caries prevention. In order to avoid difficulties in maintaining oral 
hygiene and the implementation of necessary dental procedure, early signs of trismus should 
be recognized.
7.1. Radiation caries
Radiation caries is primarily a consequence of salivary hypofunction, saliva composition 
changes, and increase in acidogenic bacteria number. Furthermore, direct damage on the 
hard dental tissues frequently occurs from RT. For caries prevention good preoperative 
 dental treatment, frequent dental evaluation and treatment after RT, consistent home care 
that includes brushing after meals and before bed, daily flossing, plaque control, self‐applied 
fluoride products, and restricted intake of cariogenic foods are required [54].
It is considered that the fluoride therapy is the best option for the prevention and treatment 
of radiation caries. The use of fluoride products significantly reduces caries activity in postRT 
patients. High concentrated fluorides (≥5000 ppm) directly applied on tooth surfaces or with 
custom‐made carriers should be maintained every day. Literature data have demonstrated no 
significant difference on caries activity related to the type of fluoride gel or fluoride delivery 
system [71].
Chlorhexidine (CHX) as a bisguanide with bactericidal activity reduces plaque accumulation 
and helps in reducing mainly Gram‐positive and bit less Gram‐negative bacteria. It is interest-
ing that use of CHX has shown decrease in oral Streptococcus mutans, with no influence on oral 
lactobacillus counts [72, 73]. Generally, CHX is recommended for maintaining oral health, 
although potential side effects such as tooth staining, taste changes, and increased calculus 
deposits should be taken into account. CHX mouthwashes should be administered daily after 
tooth brushing [71].
In cases where radiation caries is not possible to prevent, restoration with a proper dental 
material is required. Lack of salivary buffering, reduction of normal plaque pH, and forma-
tion of the hydrofluoric acid in patients with xerostomia lead to erosion of glass ionomer 
restorations [74]. Hence, conventional glass ionomer restorations are not recommended in 
patients who have been treated with RT. For the dental restoration in patients who have been 
treated with RT, the use of resin‐modified glass ionomer, composite resin, and amalgam res-
torations are recommended [71].
7.2. Trismus
Reduced mouth opening is a result of the damaging effects of RT on the masticatory muscles. 
It is very important to identify early signs of trismus considering the fact that early treatment 
can significantly affect its prevention. For the prevention as well as for the treatment of reduced 
mouth opening, passive and active physiotherapy from the commencement of RT can be per-
formed. Active physiotherapy is carried out with the muscles placed around the joint, while 
passive motion includes use of various devices [33]. Passive physiotherapy implies the use of 
tongue depressors, a hand operated device “Therabite Jaw Motion Rehabilitation System,“, and 
forced mouth opening with finger pressure several times a day [75]. Except of the aforemen-
tioned therapeutic options, pentoxifylline and botulinum toxins have shown efficacy in reducing 
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radiation‐induced trismus [76, 77]. However, the latter needs to be confirmed by randomized 
controlled studies. Whenever possible, sophisticated multiple‐field techniques should be used to 
reduce the dose of radiation to the mastication muscles and temporomandibular joint [2].
7.3. Osteoradionecrosis
Head and neck cancer patients undergoing RT are at lifelong risk of developing ORN. Therefore, 
dental extractions after RT should be avoided if possible. Furthermore, every local trauma must 
be avoided, and endodontic therapy, instead of extractions, should be the treatment of choice. 
Otherwise, if there is a need for extractions in postradiation period, they should be performed 
during first 5–6 months after RT with minimal trauma and primary closure [25]. Obliteration 
of the blood vessels and hypovascularity of the bone that occurs after RT is not an overnight 
process and it takes 5–6 months to develop [20, 50]. This “window” period should therefore be 
used for necessary extractions if possible. Literature results on the incidence of ORN after tooth 
extraction support this as significantly lower incidence of ORN was reported when extractions 
were performed within 1 year postRT compared to extractions performed 2–5 years postRT 
(7.5% vs. 22.6%) [78]. Use of antibiotic prophylaxis for the prevention of ORN is widespread in 
the literature, but there is no consensus on the type and dose of application. Their administra-
tion is empirical [23]. Hyperbaric oxygen therapy (HBO) is not strongly recommended for the 
prevention of ORN prior dental extractions, due to unclear clinical efficacy and cost‐effective-
ness. No specific and universally accepted guideline for the administration of HBO therapy 
exists [22]. Most of the protocols propose 20–30 dives before and 10 dives after dental extrac-
tion at 2.0–2.5 atmosphere pressure [22, 23]. Despite that, recent Cochrane systematic review 
concluded that HBO therapy “appears to reduce the chance of ORN following tooth extraction 
in an irradiated field” and that “the application of HBOT to selected participants and tissues 
may be justified” [79].
Management of ORN includes conservative treatment, surgical debridement with the use 
of adjunctive antibiotics and reconstructive surgery. Conservative treatment should be the 
first line therapy for ORN because surgical procedure may enhance the necrotic process [23]. 
Treatment consists of local wound care and good oral hygiene using 0.2% chlorhexidine 
mouthwashes and course of systemic antibiotics in acute episodes [80, 81]. If a conservative 
Oral care after head and neck radiotherapy
• regular checkups every 4–8 weeks for the first 6 months (afterwards based on the patient's needs)
• avoid invasive surgical procedures including dental extractions (if necessary, the use of antibiotics and HBO 
therapy before and after surgery should be considered)
• daily fluoride application (using a tray or brush‐on method), flossing and meticulous oral hygiene (use a soft 
toothbrush and 0.02% CHX mouthwash) must be performed
• management of dry mouth (sip water frequently, use saliva substitutes, sugar‐free candies, and gums)
• exercises for the jaw muscles at least three times a day (minimum first 6 months postRT)
• a new removable denture can be made 3–6 months postRT (avoid any tissue irritation/trauma)
Table 2. Oral care after head and neck radiotherapy (modified from Refs. [68–70]).
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approach does not achieve wound healing, surgical removal of necrotic bone is indicated. 
Indications for reconstructive surgery include advanced cases with oral and/or cutaneous 
fistula, radiographically visible osteolysis, and pathologic fracture [81, 82]. The use of anti-
oxidant agent pentoxifylline and tocopherol (vitamin E) for the treatment of ORN has shown 
promising results but more clinical trials are needed to confirm their efficacy [82].
Points to remember for the oral care after head and neck RT are presented in Table 2 [68–70].
8. Conclusion
Efforts of dental professionals will have a significant clinical and financial impact on the 
treatment of PwHNT. The dentist must be a member of the oncology team and must have 
knowledge on the specific complications of head and neck RT. Dentist should make a plan of 
treatment and prevention before the start of RT. Surgeons, radiation oncologists, and medical 
oncologists can find valuable partners in dental profession, with the aim of improving patients’ 
overall quality of life. Such care can greatly prevent and reduce side effects of treatment, 
resulting in a significant reduction in the cost of treatment, and some of those aspects facili-
tate implementation of radiation therapy without interruption, which increases the chances 
of cure.
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